药明生物预期2025年收入将实现加速增长

格隆汇
13 Jan

格隆汇1月13日丨药明生物(02269.HK)公告,公司将于2025年1月15日出席第43届年度摩根大通医疗健康大会,会上将进行包含公司业务营运的若干资讯的简报。集团业务及财务状况依然强健,于2024年新增151个项目,项目总数达到817个(其中包括66个临床III期及21个非新冠CMO(商业化生产)项目)。此外,集团于2024年通过研究®平台赋能7个分子研究服务的全球项目,并有权于近期收取约...

Source Link

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Most Discussed

  1. 1
     
     
     
     
  2. 2
     
     
     
     
  3. 3
     
     
     
     
  4. 4
     
     
     
     
  5. 5
     
     
     
     
  6. 6
     
     
     
     
  7. 7
     
     
     
     
  8. 8
     
     
     
     
  9. 9
     
     
     
     
  10. 10